Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma. (April 2018)
- Record Type:
- Journal Article
- Title:
- Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma. (April 2018)
- Main Title:
- Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma
- Authors:
- Dy, Tiffany
Lewis, Ericka M.
Murugan, Vithya
Gehlert, Sarah
Taylor, Juanita
Garbutt, Jane
Bacharier, Leonard B.
Castro, Mario
Sumino, Kaharu - Abstract:
- Abstract: Objectives: Guidelines recommend that healthcare providers adjust the dose of inhaled corticosteroids (ICS) in asthma patients based on the degree of symptom severity and control. Symptom-based, intermittent ICS therapy (use of ICS together with short acting bronchodilators- symptom-based adjustment: SBA) has been demonstrated to be comparable to guideline-based management by providers in controlled clinical trials. We sought input from African American caregivers and pediatricians on the acceptability and barriers for this alternative management strategy. Methods: Focus group interviews of caregivers and individual interviews with community providers of African-American children ages 6–17 years with mild-moderate persistent asthma were conducted by trained facilitators to assess perceptions of how asthma affects children and their caregivers, and of SBA as a management strategy. Interview data were transcribed and analyzed using inductive thematic based coding. Results: Twenty-six parents participated in six focus groups. Fourteen pediatricians were interviewed. Caregivers reported facing financial burden and difficulty with tracking medications. Caregivers and pediatricians were favorable about SBA, citing its potential for decreased use of medications and cost and similarity to actual care provided. Some caregivers voiced concern that SBA would not be as effective as daily ICS. Caregivers suggested that education on symptom recognition and close communicationAbstract: Objectives: Guidelines recommend that healthcare providers adjust the dose of inhaled corticosteroids (ICS) in asthma patients based on the degree of symptom severity and control. Symptom-based, intermittent ICS therapy (use of ICS together with short acting bronchodilators- symptom-based adjustment: SBA) has been demonstrated to be comparable to guideline-based management by providers in controlled clinical trials. We sought input from African American caregivers and pediatricians on the acceptability and barriers for this alternative management strategy. Methods: Focus group interviews of caregivers and individual interviews with community providers of African-American children ages 6–17 years with mild-moderate persistent asthma were conducted by trained facilitators to assess perceptions of how asthma affects children and their caregivers, and of SBA as a management strategy. Interview data were transcribed and analyzed using inductive thematic based coding. Results: Twenty-six parents participated in six focus groups. Fourteen pediatricians were interviewed. Caregivers reported facing financial burden and difficulty with tracking medications. Caregivers and pediatricians were favorable about SBA, citing its potential for decreased use of medications and cost and similarity to actual care provided. Some caregivers voiced concern that SBA would not be as effective as daily ICS. Caregivers suggested that education on symptom recognition and close communication between physician and patient would facilitate the implementation of SBA. Conclusions: SBA was generally viewed favorably by caregivers and providers of African American children. However, concerns regarding effectiveness of SBA were voiced by both caregivers and providers. Patient education and provider-patient communication is important in implementing this alternative asthma management strategy. Highlights: Managing asthma by taking inhaled steroids with symptoms may be an alternative way. Caregivers of African American children states challenges of daily inhaled steroids. Many caregivers viewed intermittent inhaled steroids as acceptable alternative. Caregivers and pediatricians expressed concerns about effectiveness. Patient education is essential for transitioning to intermittent therapy. … (more)
- Is Part Of:
- Respiratory medicine. Volume 137(2018)
- Journal:
- Respiratory medicine
- Issue:
- Volume 137(2018)
- Issue Display:
- Volume 137, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 137
- Issue:
- 2018
- Issue Sort Value:
- 2018-0137-2018-0000
- Page Start:
- 201
- Page End:
- 205
- Publication Date:
- 2018-04
- Subjects:
- Intermittent therapy -- Patient centered treatment -- Adherence -- Qualitative study
ICS inhaled corticosteroids -- SBA symptom based adjustment -- LTRA leukotriene receptor antagonist -- LABA long acting beta agonist
Chest -- Diseases -- Periodicals
Chest -- Diseases -- Great Britain -- Periodicals
Respiratory organs -- Diseases -- Periodicals
Respiratory Tract Diseases -- Periodicals
Appareil respiratoire -- Maladies -- Périodiques
Thorax -- Maladies -- Périodiques
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Electronic journals
616.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09546111 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09546111 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09546111 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.rmed.2018.03.001 ↗
- Languages:
- English
- ISSNs:
- 0954-6111
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.661900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6264.xml